ID28810A - Senyawa-senyawa amida-omega asam n-arilsulfonilamino - Google Patents

Senyawa-senyawa amida-omega asam n-arilsulfonilamino

Info

Publication number
ID28810A
ID28810A IDW00200100995A ID20010995A ID28810A ID 28810 A ID28810 A ID 28810A ID W00200100995 A IDW00200100995 A ID W00200100995A ID 20010995 A ID20010995 A ID 20010995A ID 28810 A ID28810 A ID 28810A
Authority
ID
Indonesia
Prior art keywords
arilsulfonilamino
amida
compounds
omega acid
omega
Prior art date
Application number
IDW00200100995A
Other languages
English (en)
Inventor
Wilfried Schwab
Werner Thorwart
Manferd Schudok
Bukhard Haase
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of ID28810A publication Critical patent/ID28810A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IDW00200100995A 1998-11-06 1999-10-21 Senyawa-senyawa amida-omega asam n-arilsulfonilamino ID28810A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19851184A DE19851184A1 (de) 1998-11-06 1998-11-06 N-Arylsulfonyl-aminosäure-omega-amide

Publications (1)

Publication Number Publication Date
ID28810A true ID28810A (id) 2001-07-05

Family

ID=7886902

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200100995A ID28810A (id) 1998-11-06 1999-10-21 Senyawa-senyawa amida-omega asam n-arilsulfonilamino

Country Status (23)

Country Link
US (2) US6201130B1 (id)
EP (1) EP1124797B1 (id)
JP (1) JP4348014B2 (id)
KR (1) KR100655632B1 (id)
CN (1) CN1206213C (id)
AR (1) AR021086A1 (id)
AT (1) ATE260889T1 (id)
AU (1) AU757602B2 (id)
BR (1) BR9915729A (id)
CA (1) CA2350031C (id)
CZ (1) CZ302291B6 (id)
DE (2) DE19851184A1 (id)
DK (1) DK1124797T3 (id)
ES (1) ES2213405T3 (id)
HK (1) HK1041686B (id)
HU (1) HUP0104122A3 (id)
ID (1) ID28810A (id)
PL (1) PL198827B1 (id)
PT (1) PT1124797E (id)
RU (1) RU2228330C2 (id)
TR (1) TR200101245T2 (id)
WO (1) WO2000027808A1 (id)
ZA (1) ZA200103485B (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
US7071223B1 (en) * 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
BRPI0409428A (pt) * 2003-04-15 2006-04-18 Warner Lambert Co derivados de prolina bicìclicos [c]-fundidos e a sua utilização para tratar estados artrìticos
BRPI0410349A (pt) * 2003-05-12 2006-05-30 Pfizer Prod Inc inibidores de benzamida do receptor p2x7
KR20070115583A (ko) * 2004-06-29 2007-12-06 화이자 프로덕츠 인코포레이티드 루이스 산의 존재하에 트리아진의 4-위치에서 치환되지않은5-[4-(2-하이드록시-에틸)-3,5-다이옥소-4,5-다이하이드로-3ｈ-[1,2,4]트리아진-2-일]-벤즈아마이드 유도체와옥시란과의 반응에 의해 ｐ2ｘ7 억제 활성을 갖는 상기유도체의 제조방법
WO2006003517A1 (en) * 2004-06-29 2006-01-12 Warner-Lambert Company Llc Combination therapies utilizing benzamide inhibitors of the p2x7 receptor
WO2006003500A1 (en) * 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
PE20070505A1 (es) * 2005-07-11 2007-05-15 Wyeth Corp Inhibidores de glutamato de metaloproteinasas de matriz y agrecanasas
GT200600305A (es) 2005-10-13 2007-02-26 Métodos para preparar derivados de acido glutamico
ES2533065T3 (es) 2010-07-09 2015-04-07 Pfizer Limited Bencenosulfonamidas útiles como inhibidores de los canales de sodio
WO2014121884A1 (en) * 2013-02-06 2014-08-14 Merck Patent Gmbh Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1063026A1 (ru) * 1982-05-19 1990-12-07 Институт биохимии АН ЛитССР N @ -Бензолсульфонильные производные трес-DL-фенилсерина, обладающие противовоспалительной активностью
JP2764262B2 (ja) 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (id) 1990-07-05 1993-03-01 Hoffmann La Roche
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5962529A (en) 1994-06-22 1999-10-05 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
AU6482396A (en) * 1995-06-28 1997-01-30 E.I. Du Pont De Nemours And Company Fluoropolymer nanocomposites
KR980009238A (ko) 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
JP2000511175A (ja) * 1996-05-17 2000-08-29 ワーナー―ランバート・コンパニー ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren

Also Published As

Publication number Publication date
DE59908769D1 (de) 2004-04-08
HK1041686A1 (en) 2002-07-19
HK1041686B (zh) 2005-09-23
CA2350031A1 (en) 2000-05-18
RU2228330C2 (ru) 2004-05-10
CZ302291B6 (cs) 2011-02-09
AR021086A1 (es) 2002-06-12
KR100655632B1 (ko) 2006-12-12
BR9915729A (pt) 2001-10-23
PL198827B1 (pl) 2008-07-31
DK1124797T3 (da) 2004-07-05
HUP0104122A2 (hu) 2002-03-28
JP2002529447A (ja) 2002-09-10
JP4348014B2 (ja) 2009-10-21
US6201130B1 (en) 2001-03-13
ZA200103485B (en) 2001-12-04
TR200101245T2 (tr) 2001-10-22
KR20010080385A (ko) 2001-08-22
CN1332724A (zh) 2002-01-23
WO2000027808A1 (de) 2000-05-18
ES2213405T3 (es) 2004-08-16
CZ20011506A3 (cs) 2001-08-15
EP1124797B1 (de) 2004-03-03
PT1124797E (pt) 2004-07-30
PL347574A1 (en) 2002-04-08
EP1124797A1 (de) 2001-08-22
US6335333B1 (en) 2002-01-01
AU1153000A (en) 2000-05-29
CA2350031C (en) 2010-01-26
HUP0104122A3 (en) 2002-04-29
AU757602B2 (en) 2003-02-27
ATE260889T1 (de) 2004-03-15
CN1206213C (zh) 2005-06-15
DE19851184A1 (de) 2000-05-11

Similar Documents

Publication Publication Date Title
ID26222A (id) Hidroksamida asam(4-arilsulfonilamino)-tetrahidropiran-4-karboksilat
ID28833A (id) Turunan asam 3-aril-2-hidroksipropionat
ID20809A (id) Asam diaminokarboksilat tersubstitusi
ATE269861T1 (de) Substituierte indolalkansäure
ID28699A (id) Turunan-turunan asam oksiiminoalkanoat
ID22095A (id) Asam aril-akrilat ester
ID20807A (id) Asam sulfonilaminokarboksilat
ID26978A (id) Turunan-turunan asam aminometilkarboksilat
LTC1124961I2 (lt) Trombopoetino junginiai
ID24626A (id) Turunan-turunan asam hidroksamat sebagai penghambat metaloprotease matriks (mmp)
ATE229954T1 (de) Betacarbolinverbindungen
ID23668A (id) Turunan asam ariloksiarilsulfonilamino hidroksamat
ID28266A (id) Senyawa-senyawa amidin
ID24376A (id) Turunan-turunan asam amidokarboksilat
ID28164A (id) Turunan iii asam 3-aril-2-hidroksipropionat baru
NO20011745L (no) Forbindelser
ID27390A (id) Pembuatan asam akrilat
NO20005006L (no) Kalsilytiske forbindelser
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
ID28810A (id) Senyawa-senyawa amida-omega asam n-arilsulfonilamino
NO20006662L (no) Fluorfenylresin-forbindelser
NO991561L (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
ID27729A (id) Komposisi-komposisi anti-enzim yang mengandung asam etilendiamin disuksinat
ID21355A (id) Pembuatan asam adipat
DE69818457D1 (de) Aromatische sulphonyl-alpha-hydroxy-hydroxamsäureverbindungen